The Tamil Nadu government has issued a ban on the sale of the cough syrup ColdRif and mandated its removal from the market. This action follows suspicions linking the product to the deaths of 11 children in Madhya Pradesh and Rajasthan. The ban, effective from October 1st, prohibits the sale of the cough syrup, which is manufactured by a city-based firm, throughout Tamil Nadu. Inspections were immediately conducted at the pharmaceutical company’s manufacturing facility in Sunguvarchathram, Kancheepuram district, over a two-day period. Samples of the syrup have been collected and are slated for testing to determine the presence of Diethylene Glycol, a potentially harmful chemical. Furthermore, the Union Ministry issued an advisory to all states and union territories, recommending against prescribing cough and cold medications to children under the age of 2.
